Graphene oxide selectively targets cancer stem cells, across multiple tumor types: Implications for non-toxic cancer treatment, via “differentiation-based nano-therapy”

Tumor-initiating cells (TICs), a.k.a. cancer stem cells (CSCs), are difficult to eradicate with conventional approaches to cancer treatment, such as chemo-therapy and radiation. As a consequence, the survival of residual CSCs is thought to drive the onset of tumor recurrence, distant metastasis, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiorillo, Marco, Verre, Andrea F., Iliut, Maria, Peiris-Pagés, Maria, Ozsvari, Bela, Gandara, Ricardo, Cappello, Anna Rita, Sotgia, Federica, Vijayaraghavan, Aravind, Lisanti, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414136/
https://www.ncbi.nlm.nih.gov/pubmed/25708684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414136/
https://www.ncbi.nlm.nih.gov/pubmed/25708684

Ejemplares similares